Credits Available: 4.75 hours of AMA PRA Category 1 Credit

Description: Patients who are living with obesity or overweight may seek care with an endocrinologist for other comorbidities, some of which may be directly linked to their weight. Weight reduction and management using pharmacotherapy, including GLP-1 RAs, can be a useful strategy to help patients improve not only their weight but also their metabolic health. Through this program, endocrinologists will gain a deeper understanding of how they can appropriately select patients who may benefit from GLP-1 RAs, especially if they have other comorbidities, and apply clinical trial findings to everyday patient care. They will also enhance their understanding of strategies which can improve both patient adherence and payor authorization/approval.

Obesity Medicine Association Logo

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Endocrinology

Ashlyn Smith

Ashlyn Smith
PA-C

Ashlyn Smith has practiced adult endocrinology in Phoenix, AZ, since 2013 after practicing in internal medicine and pediatric endocrinology. In addition to patient care, she also manages a multidisciplinary regional tele-endocrinology program. Ashlyn stays active in the medical community by lecturing at the local, state, and national levels. She currently serves as Immediate Past President on the board of directors for the American Society of Endocrine Physician Assistants and Adjunct Assistant Professor at Midwestern University in Glendale, AZ. Ashlyn was a recipient of the 2024, 2022, and 2019 America’s Top PA Awards.